Ohio joins Indiana and Kentucky in funding Pear Therapeutics’ digital addiction treatments

By SharpBrains | April 26, 2021

Ohio is third state to fund Pear’s dig­i­tal ther­a­peu­tics to tack­le addic­tion (phar­mafo­rum): The com­pa­ny has been push­ing for more reim­burse­ment of its three mar­ket­ed DTx prod­ucts in the US fol­low­ing a first FDA approval in 2017. Pear said that the Ohio Depart­ment of Men­tal Health and Addic­tion Ser­vices (OhioMHAS) and Recov­ery­Ohio are pro­vid­ing access to…

Read More

Pear Therapeutics raises $80M; finds cost savings of $2,150 per patient with opioid use disorder

By SharpBrains | December 11, 2020

Pear Ther­a­peu­tics rais­es $80M in push for reim­burse­ment (Med­C­i­ty News): Pear Ther­a­peu­tics raised $80 mil­lion in fund­ing, which it plans to use as part of a push for cov­er­age of its dig­i­tal ther­a­peu­tics. The Boston-based com­pa­ny has three FDA-cleared prod­ucts, includ­ing dig­i­tal ther­a­peu­tics for sub­stance use dis­or­der, opi­oid use dis­or­der, and most recent­ly, insomnia.

Read More